Track topics on Twitter Track topics that are important to you
This KOL Insight briefing focuses on KOLs views of Rituximab Use in Lupus.
Current future use of RTX in lupus
Views on RTX's Phase II/III EXPLORER trial reanalysis
Opinion on data demonstrating that RTX is effective for the management of refractory SLE
Views on data from the Phase II SYNBIoSe study assessing RTX + BEL combination therapy
Lupus patients most suitable for RTX + BEL combination therapy
Use of RTX + BEL combination therapy
Most US KOLs stated that future launch of biosimilar RTX will have no impact on their overall use of RTX, but uptake will depend on price
Most KOLs highlighted that the level of background medication used in the EXPLORER trial was too high and consequently impeded results
Most KOLs flagged that payers may be a barrier to combination therapy use, especially given the lack of approval for RTX in lupus.
The insight briefing is based on Sociable Pharma's analysis of primary research with our Lupus key opinion leaders KOLs.
In total, we conducted interviews with 10 KOLs
5 Europebased 5 N. Americabased
Interviews performed during Q2 2018
KOL data is analyzed to produce
Charts summarizing KOL opinions
Chart callouts of key information details
Summary of KOL reporting trends
Insight from Sociable Pharma's analysts
Reasons to buy
Combines Qualitative semiquantitative insight from key opinion leaders on Rituximab Use in Lupus
Includes insight recommendations from our diseasespecific healthcare analysts
Utilizes independent expert viewpoints to validate the impact of new clinical data emerging trends on management of Lupus
Provides costeffective support for your advisory boards, with topics acting as a catalyst for further expert discussion.NEXT ARTICLE
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...
Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells. Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...